Therapeutic uses of leuprolide acetate
US6099851A · kind A · utility
101Cited by
1References
6Claims
0Family size
Inventors
Key dates
| Filing date | Jun 2, 1998 |
| Grant date | Aug 8, 2000 |
| Priority date | — |
| Expiry date | Jun 2, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of decreasing atherosclerosis and its complications including but not limited to myocardial infarction, stroke and peripheral vascular disease comprising administering to a human or animal an amount of Leuprolide acetate is sufficient to decrease atherosclerosis and its complications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.